Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series) - Image 1

£42.72

Chapman and Hall/CRC Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Name: Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
Brand: Chapman and Hall/CRC
Price: 42.31 GBP
Availability: InStock

Public Health

Price History & Forecast

Last 36 days • 36 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 36 days • 1 price levels

Days at Price

Price Analysis

Most common price: £42 (36 days, 100.0%)

Price range: £42 - £42

Price levels: 1 different prices over 36 days

Description

Real-world evidence is defined as evidence generated from real-world data outside randomized controlled trials. As scientific discoveries and methodologies continue to advance, real-world data and their companion technologies offer powerful new tools for evidence generation. Real-World Evidence in a Patient-Centric Digital Era provides perspectives, examples, and insights on the innovative application of real-world evidence to meet patient needs and improve healthcare, with a focus on the pharmaceutical industry. This book presents an overview of key analytical issues and best practices. Special attention is paid to the development, methodologies, and other salient features of the statistical and data science techniques that are customarily used to generate real-world evidence. It provides a review of key topics and emerging trends in cutting-edge data science and health innovation. Features: Provides an overview of statistical and analytic methodologies in real-world evidence to generate insights on healthcare, with a special focus on the pharmaceutical industry Examines timely topics of high relevance to industry such as bioethical considerations, regulatory standards, and compliance requirements Highlights emerging and current trends, and provides guidelines for best practices Illustrates methods through examples and use-case studies to demonstrate impact Provides guidance on software choices and digital applications for successful analytics Real-World Evidence in a Patient-Centric Digital Era will be a vital reference for medical researchers, health technology innovators, data scientists, epidemiologists, population health analysts, health economists, outcomes researchers, policymakers, and analysts in the healthcare industry.

Key Features

New Store Stock

Product Specifications

Brand: Chapman and Hall/CRC
Format: paperback
ASIN: 103230362X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 26 August 2024
Listed Since: 22 June 2024

Barcode

No barcode data available

Chapman and Hall/CRC Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Clinical and Statistical Considerations in Personalized Medicine (Chapman & Hall/CRC Biostatistics)

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

Healthcare Data Analytics (Chapman & Hall/CRC Data Mining and Knowledge Discovery Series)

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

Estimands, Estimators and Sensitivity Analysis in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Real World Health Care Data Analysis: Causal Methods and Implementation Using SAS®: Causal Methods and Implementation Using SAS®

Practical Statistics for Medical Research (Chapman & Hall/CRC Texts in Statistical Science)

Healthcare Data Analytics (Chapman & Hall/CRC Data Mining and Knowledge Discovery Series)

Interval-Censored Time-to-Event Data: Methods and Applications (Chapman & Hall/CRC Biostatistics Series)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press Bayesian Methods in Pharmaceutical Research Book

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)